Structured pain assessment in post-mastectomy pain syndrome links mixed pain to multiple sources and radiotherapy
This retrospective analysis of prospectively maintained data included 120 women with refractory post-mastectomy pain syndrome referred to a tertiary cancer-related pain clinic. The study involved a structured clinical assessment to classify pain phenotypes as nociceptive, neuropathic, or mixed, comparing these categories to identify factors associated with mixed pain. The distribution of pain phenotypes was nociceptive 40.8%, neuropathic 25.0%, and mixed 34.2%, with no significant differences reported (all p > 0.05). Multiplicity of pain sources was independently associated with mixed pain, with an adjusted odds ratio of 49.96 (95% CI 11.69–213.41). Radiotherapy-attributed pain was also independently associated with mixed pain, with an adjusted odds ratio of 5.75 (95% CI 1.15–28.82). Secondary outcomes included pain intensity, interference, and catastrophizing scores, but specific results for these were not reported. Safety and tolerability data, including adverse events and discontinuations, were not reported. Key limitations include the observational design, which precludes causal inferences, and model limitations that may affect generalizability. The authors note that results should be interpreted as hypothesis-generating, with no overstatement of causality or clinical outcomes beyond pain classification. Practice relevance suggests that mechanism-based assessment may help inform individualized management strategies, but this requires validation in prospective studies.